Rezultati

eNauka >  Results >  The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics
Title: The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics
Authors : Jardine, Meg J.; Mahaffey, Kenneth W.; ...; CREDENCE study investigators; ...; Lalić, Katarina  ; Lalić, Nebojša ; ...
Issue Date: 2017
Publication: American Journal of Nephrology
ISSN: 0250-8095 American Journal of Nephrology Search Idenfier
Publisher: Basel ; New York : Karger
Type: Article
Collation: vol. 46 br. 6 str. 462-472
DOI: 10.1159/000484633
WoS-ID: 000418899500005
Scopus-ID: 2-s2.0-85038113623
PMID: 29253846
PMCID: PMC5804835
URI: https://enauka.gov.rs/handle/123456789/867007
URL: https://karger.com/ajn/article/46/6/462/41508/The-Canagliflozin-and-Renal-Endpoints-in-Diabetes
Metadata source: (Preuzeto iz CrossRef-a) Lalić, Katarina
M-category: 
21M21

212
SCOPUSTM
96
PubMed CentralTM
181
OpenCitations
200
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.